Target intelligence / Profile preview

Cyclin H pseudogene 1 (CCNHP1)

Target: CCNHP1
Molecular classification: Other (Pseudogene)

Overview

Cyclin H pseudogene 1 (CCNHP1) is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but is generally nonfunctional due to mutations or lack of regulatory elements necessary for expression. It does not encode a functional protein and is not implicated as a direct therapeutic target. Unlike its parental gene, cyclin H (CCNH), which is a crucial regulator of cell cycle progression via interaction with cyclin-dependent kinases, CCNHP1 lacks a protein product and has no established roles in physiological or disease-related processes[3][10].

Other names: Cyclin H Pseudogene 1CCNHP1

Beyond the preview

Go deeper on Cyclin H pseudogene 1 (CCNHP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin H pseudogene 1 (CCNHP1).

Explore the full profile